Submit your email to push it up the queue
Diplomat Pharmacy, Inc., a leading specialty pharmacy headquartered in the United States, has been at the forefront of the pharmaceutical industry since its founding in 1975. With a strong presence in major operational regions across the country, Diplomat focuses on providing comprehensive medication management and support services for patients with complex health conditions. The company is renowned for its unique approach to specialty pharmacy, offering tailored solutions that include medication therapy management, patient education, and adherence support. Diplomat's commitment to personalised care has positioned it as a trusted partner for healthcare providers and patients alike. Notable achievements include its recognition as one of the largest independent specialty pharmacies in the US, underscoring its significant market position and dedication to improving patient outcomes.
How does Diplomat Pharmacy, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Diplomat Pharmacy, Inc.'s score of 72 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Diplomat Pharmacy, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of UnitedHealth Group Incorporated, which means that any climate commitments or emissions data may be inherited from this parent organisation. As part of its corporate family relationship, Diplomat Pharmacy aligns with the climate initiatives and targets set by UnitedHealth Group. However, specific reduction targets or achievements for Diplomat Pharmacy itself are not available. The company does not have documented reduction initiatives or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In summary, while Diplomat Pharmacy, Inc. does not provide its own emissions data or specific climate commitments, it is positioned within a corporate structure that may influence its environmental strategies through its parent company, UnitedHealth Group Incorporated.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Diplomat Pharmacy, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.